Antifibrinolytics are drugs that promote blood clotting by preventing clots from breaking down. A variety of antifibrinolytic medications exist, which work in different ways. Tranexamic acid, which is a type of antifibrinolytic, has more evidence than other agents, and is evaluated as a separate intervention in the PEP evidence.